STOK SCHEDULE 13G: SEC filing

Biotechnology Value Fund entities and Mark N. Lampert

Filed with the SEC on · accession 0000921895-26-002685

STOK filed a SCHEDULE 13G (schedule 13g) with the SEC on Sep 30, 2026. Biotechnology Value Fund entities and Mark N. The stock moved +0.5% by the first close after the filing.

Summary of the filing

Biotechnology Value Fund entities and Mark N. Lampert filed a joint Schedule 13G indicating a passive ownership position in Stoke Therapeutics common stock. The filing is a joint filing agreement among affiliated BVF entities.

Key details

Filer / shareholderBiotechnology Value Fund L P
Filer / shareholderBVF I GP LLC
Filer / shareholderBiotechnology Value Fund II LP
Filer / shareholderBVF II GP LLC
Filer / shareholderBiotechnology Value Trading Fund OS LP
Filer / shareholderBVF Partners OS Ltd.
Filer / shareholderBVF GP Holdings LLC
Filer / shareholderBVF Partners L P/IL
Filer / shareholderBVF Inc/IL
IssuerStoke Therapeutics, Inc.
Authorized signatory, bvf entitiesMark N. Lampert

How STOK stock reacted

Close before

$25.88

Sep 29, 2026

First close after

+0.46%

$26.00

5 trading days

-5.83%

$24.37

Since filing

+4.29%

$26.99

✦ Ask GOAX AI about this filing — what it means for STOK, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for STOK?

Click here

Frequently asked questions

What did STOK file with the SEC on Sep 30, 2026?

STOK filed a SCHEDULE 13G (SEC filing). Biotechnology Value Fund entities and Mark N. Lampert filed a joint Schedule 13G indicating a passive ownership position in Stoke Therapeutics common stock. The filing is a joint filing agreement among affiliated BVF entities.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did STOK stock react to this filing?

STOK closed at $25.88 before the filing and $26.00 on Sep 30, 2026 (+0.46%). Five trading days later: $24.37 (-5.83%).

Other STOK SEC filings

Get alerts when STOK files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days